Publications
Main content start
Site content
- Pugh, E., Stewart, J., Carter, L., Calamia, M., Carmichael, O., & Newton, R. (2022). Beliefs, Understanding, and Barriers Related to Dementia Research Participation Among Older African Americans. 36, 52-57.
- Oyer, R., Hurley, P., Boehmer, L., Bruinooge, S., Levit, K., Barrett, N., Benson, A., Bernick, L., Byatt, L., Charlot, M., Crews, J., DeLeon, K., Fashoyin-Aje, L., Garrett-Mayer, E., Gralow, J., Green, S., Guerra, C., Hamroun, L., Hardy, C., Hempstead, B., Jeames, S., Mann, M., Matin, K., McCaskill-Stevens, W., Merrill, J., Nowakowski, G., Patel, M., Pressman, A., Ramirez, A., Segura, J., Segarra-Vasquez, B., Williams, J., Williams, J., Winkfield, K., Yang, E., Zwicker, V., & Pierce, L. (2022). Increasing Racial and Ethnic Diversity in Cancer Clinical Trials: An American Society of Clinical Oncology and Association of Community Cancer Centers Joint Research Statement.
- Omar, D., Syder, N., Brown-Korsah, J., McKenzie, S., Elbuluk, N., & Taylor, S. (2022). Racial and Ethnic Disparities in Clinical Research and the Dermatology Workforce. Elsevier Inc.
- Reza, N., Gruen, J., & Bozkurt, B. (2022). Representation of women in heart failure clinical trials: Barriers to enrollment and strategies to close the gap. Elsevier Inc., 13.
- Kahn, J., Gray, D., Oliveri, J., Washington, C., DeGraffinreid, C., & Paskett, E. (2022). Strategies to improve diversity, equity, and inclusion in clinical trials. John Wiley & Sons, Ltd.
- Garrick, O., Mesa, R., Ferris, A., Kim, E., Mitchell, E., Brawley, O., Carpten, J., Carter, K., Coney, J., Winn, R., Monroe, S., Sandoval, F., Perez, E., Williams, M., Grove, E., Highsmith, Q., Richie, N., Begelman, S., Collins, A., & Freedman, J. (2022). Advancing Inclusive Research: Establishing Collaborative Strategies to Improve Diversity in Clinical Trials. 32, 61-68.
- Watson, K., Cohn, E., Fair, A., Menon, U., Szalacha, L., Carpenter, S., & Wilkins, C. (2022). Adapting a conceptual framework to engage diverse stakeholders in genomic/precision medicine research. Wiley-Blackwell, 25, 1478-1485.
- Gross, A., Harry, A., Clifton, C., & Pasqua, O. (2022). Clinical trial diversity: An opportunity for improved insight into the determinants of variability in drug response. 88, 2700-2717.
- McFarlane, S., Occa, A., Peng, W., Awonuga, O., & Morgan, S. (2022). Community-Based Participatory Research (CBPR) to Enhance Participation of Racial/Ethnic Minorities in Clinical Trials: A 10-Year Systematic Review. 37, 1075-1092.
- Boden-Albala, B. (2022). Confronting legacies of underrepresentation in clinical trials: The case for greater diversity in research. Cell Press, 110, 746-748.
- Macdonald, G. (2022). Data key to boosting trial diversity--and its time for CROs to act, says Phesi. Questex Media Group, N.PAG-N.PAG.
- Green, A., Trivedi, N., Hsu, J., Yu, N., Bach, P., & Chimonas, S. (2022). Despite The FDA’s Five-Year Plan, Black Patients Remain Inadequately Represented In Clinical Trials For Drugs. 41, 368-374.
- Isaacs, T., Murdoch, J., Demj?n, Z., & Stevenson, F. (2022). Examining the language demands of informed consent documents in patient recruitment to cancer trials using tools from corpus and computational linguistics. Sage Publications, 26, 431-456.
- Chapagain, R., Adhikari, S., Giri, B., Ray, P., Shrestha, N., Prajapati, B., Joshi, P., Pokharel, S., Tamang, S., Gupta, B., Wartel, A., Sahastrabuddhe, S., Rai, G., & Saluja, T. (2022). Factors affecting willingness to participate in vaccine clinical trials in an underdeveloped country: perspective from Nepal. Taylor & Francis, 18, 2051413.
- Shea, L., Pesa, J., Geonnotti, G., Powell, V., Kahn, C., & Peters, W. (2022). Improving diversity in study participation: Patient perspectives on barriers, racial differences and the role of communities. Wiley-Blackwell, 25, 1979-1987.
- Kallsen, K., O’Neill, P., Ousmanou, A., Patil, B., Preciado, K., Price, J., Sanford, K., Sayers, R., Shaw, K., & Sigman, J. (2022). Redefining Patient-Centricity: Exploring the Next Best in People, Processes and Technology for the Future of Decentralized Clinical Trials: How patient-centric initiatives guide the clinical drug development Sponsored by process towards increased inclusiv. MJH Life Sciences, 31, 12-17.
- Gonzalez, G., Dallas, K., Arora, A., Kobashi, K., & Anger, J. (2022). Underrepresentation of Racial and Ethnic Diversity in Research Informing the American Urological Association/Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Stress Urinary Incontinence Guideline. Elsevier Science, 163, 16-21.
- Rai, T., Hinton, L., McManus, R., & Pope, C. (2022). What would it take to meaningfully attend to ethnicity and race in health research? Learning from a trial intervention development study. 1.
- Kusnoor, S., Villalta-Gil, V., Michaels, M., Joosten, Y., Israel, T., Epelbaum, M., Lee, P., Frakes, E., Cunningham-Erves, J., Mayers, S., Stallings, S., Giuse, N., Harris, P., & Wilkins, C. (2021). Design and implementation of a massive open online course on enhancing the recruitment of minorities in clinical trials - Faster Together. BioMed Central, 21.